BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2279542)

  • 21. Human recombinant interferon-alpha-2 in the treatment of patients with hairy cell leukemia.
    Skotnicki AB; Wolska-Smolen T; Blicharski J; Zduńczyk A; Sasiadek U; Pituch-Noworolska A
    Cancer Detect Prev; 1988; 12(1-6):511-22. PubMed ID: 3180143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole blood assay for NK activity in splenectomized and non-splenectomized hairy cell leukemia patients during IFN-alpha-2b treatment.
    Nielsen B; Hokland P; Ellegaard J; Hasselbalch H; Hokland M
    Leuk Res; 1989; 13(6):451-6. PubMed ID: 2770329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human lymphoblastoid alpha-interferon for hairy cell leukemia. An update of the Italian Cooperative Group.
    Federico M; Frassoldati A; Pagnucco G; Lamparelli T; Capnist G; Chisesi T; Guarnaccia C; Lauria F; Resegotti L; Rossi G
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():179-81. PubMed ID: 2653499
    [No Abstract]   [Full Text] [Related]  

  • 24. Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients.
    Golomb HM; Jacobs A; Fefer A; Ozer H; Thompson J; Portlock C; Ratain M; Golde D; Vardiman J; Burke JS
    J Clin Oncol; 1986 Jun; 4(6):900-5. PubMed ID: 3519880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
    Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
    Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Low-dose alpha-interferon treatment of hairy cell leukemia].
    von Wussow P; Freund M; Block B; Diedrich H; Schmoll H; Poliwoda H; Deicher H
    Klin Wochenschr; 1987 Jul; 65(14):681-4. PubMed ID: 3626433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early response to alpha interferon in a patient affected by hairy cell leukemia.
    Di Raimondo F; Murolo D; Milone G; Cacciola E; Giustolisi R
    Haematologica; 1992; 77(4):355-6. PubMed ID: 1427445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of interferon-alpha administration after 2-deoxycoformycin in the treatment of hairy cell leukemia patients.
    Marotta G; Frassoldati A; Zinzani P; Annino L; Brugiatelli M; Ambrosetti A; Lenoci M; Federico M; Foa R; Lauria F;
    Eur J Haematol; 2006 Aug; 77(2):109-13. PubMed ID: 16856905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pentostatin treatment for hairy cell leukemia patients who failed initial therapy with recombinant alpha-interferon: a report of CALGB study 8515.
    Golomb HM; Dodge R; Mick R; Budman D; Hutchison R; Horning SJ; Schiffer CA
    Leukemia; 1994 Dec; 8(12):2037-40. PubMed ID: 7807991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland.
    Robak T; Błasińska-Morawiec M; Błoński J; Hellmann A; Hałaburda K; Konopka L; Kotlarek-Haus S; Potoczek S; Hansz J; Dmoszyńska A; Urasiński I; Zdziarska B; Dwilewicz-Trojaczek J; Hołowiecki J; Skotnicki AB
    Eur J Haematol; 1999 Jan; 62(1):49-56. PubMed ID: 9918312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The treatment of hairy cell leukemia with recombinant alfa interferon: a multi-institutional study.
    Thompson JA; Fefer A
    Invest New Drugs; 1987; 5 Suppl():S5-8. PubMed ID: 3298134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon is effective in hairy-cell leukaemia.
    Worman CP; Catovsky D; Bevan PC; Camba L; Joyner M; Green PJ; Williams HJ; Bottomley JM; Gordon-Smith EC; Cawley JC
    Br J Haematol; 1985 Aug; 60(4):759-63. PubMed ID: 3875366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human lymphoblastoid interferon for hairy cell leukemia: results from the Italian Cooperative Group.
    Damasio EE; Bernasconi C; Castoldi GL; Chisesi T; Federico M; Lamparelli T; Lauria F; Pagnucco G; Resegoti L; Rossi E
    Leukemia; 1987 Apr; 1(4):331-3. PubMed ID: 3669757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relapse after interferon alfa-2b therapy for hairy-cell leukemia: analysis of prognostic variables.
    Ratain MJ; Golomb HM; Vardiman JW; Westbrook CA; Barker C; Hooberman A; Bitter MA; Daly K
    J Clin Oncol; 1988 Nov; 6(11):1714-21. PubMed ID: 3054003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon in the treatment of hairy cell leukemia.
    Thompson JA; Fefer A
    Cancer; 1987 Feb; 59(3 Suppl):605-9. PubMed ID: 3542183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Alpha interferon in the therapy of hairy cell leukemia. Results of 3 prospective multicenter studies in West Germany].
    Pralle H; Bartel A; Boedewadt-Radzun S; Bross K; Bruhn HD; Dörken B; Drees N; Essers U; Fuhr H; Gamm H
    Onkologie; 1988 Feb; 11(1):44-7. PubMed ID: 3283625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment with low dose human recombinant interferon-alpha-2-ARG induces complete remission in patients with hairy cell leukemia.
    Gastl G; Denz H; Abbrederis C; Huber H; Troppmair J; Wiegele J; Niederwieser D; Flener R; Huber C
    Onkologie; 1985 Jun; 8(3):143-4. PubMed ID: 3895095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant alpha-2 interferon for treatment of hairy cell leukemia without prior splenectomy.
    Ehmann WC; Silber R
    Am J Med; 1986 Jun; 80(6):1111-4. PubMed ID: 3728508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of hairy cell leukaemia with recombinant alpha-interferon.
    Bezwoda WR; Hesdorffer CS; Dansey RD; Lewis D
    S Afr Med J; 1987 Nov; 72(10):661-2. PubMed ID: 3686262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnosis and prognosis of hairy cell leukemia].
    Hill W; Kettner G; Burkhardt R
    Klin Wochenschr; 1987 Jul; 65(14):691-8. PubMed ID: 3626434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.